Kazakhstan country overview 2014

This summary of the national drug situation in Kazakhstan was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology Database Collection and Development). The content of this summary does not necessarily reflect the official opinion of the European Union, nor the official opinion of the Republic of Kazakhstan, and should be seen as the product of CADAP 5. 

Note that this publication is available online only.